Hashimoto, K.

Detrimental effects of COVID-19 in the brain and therapeutic options for long COVID: The role of Epstein–Barr virus and the gut–brain axis

Mol Psychiatry 28, 4968–4976 (2023)
> https://doi.org/10.1038/s41380-023-02161-5

Grande, T.; Grande, B.; Gerner, P.; Hammer, S.; Stingl, M.; Vink, M.; Hughes, B.M.

The Role of Psychotherapy in the Care of Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

Medicina 2023, 59, 719
> https://doi.org/10.3390/medicina59040719

Keywords: chronic fatigue syndrome; cognitive behavioral therapy; exercise; myalgic encephalomyelitis; pacing; psychotherapy; post-exertional malaise
Conclusion: There are several important and clear distinctions to be made between the pacing-led ME/CFS treatment approach that is outlined above and in many of the so-called ‘standard’ psychotherapeutic …weiterlesen techniques that are often used with patients in health contexts. Challenging patients’ cognitions and stress limits is so elementary to routine psychotherapeutic/psychosomatic care that doubts about so-called ‘modifications’ in the sense of a ‘particularly careful’ approach to ME/CFS patients are, in our opinion, justified. However, conventional approaches involve unfulfillable therapeutic promises and the serious danger of deterioration. We, therefore, believe that a radical paradigm shift is needed in psychotherapy, health psychology, and other fields where psychosocial and behavioral support is provided to ill people, and which recognizes the somatic nature of ME/CFS and adjusts therapeutic goals accordingly. A particular imposition of ME/CFS is the phenomenon of PEM, whose control by means of pacing demands a high degree of vigilance, discipline, and renunciation from the patients. This means an enormous challenge for those affected, which is not encountered in this specific way in other chronic diseases. A psychotherapy that takes these realities into account and offers help in coping with them can make an important and, in our view, an indispensable contribution to the care of ME/CFS patients.

Siehe auch Deutschen Gesellschaft für ME/CFS (deutsche Übersetzung)
> https://www.mecfs.de/puhttps://www.mecfs.de/wp-content/uploads/2024/02/Die-Rolle-der-Psychotherapie-in-der-Versorgung-von-Patienten-mit-MECFS_deutsch.pdfblikation-zur-psychosomatischen-sicht-auf-me-cfs/

Flaxman S, Whittaker C, Semenova E, et al.

Assessment of COVID-19 as the Underlying Cause of Death Among Children and Young People Aged 0 to 19 Years in the US

JAMA Netw Open. 2023
> https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2800816

siehe auch:
> https://www.ox.ac.uk/news/2023-01-31-covid-19-leading-cause-death-children-and-young-people-us

Monje, M.; Iwasaki, A.

The neurobiology of long COVID

Neuron, Volume 110, Issue 21, 3484 – 3496
> https://doi.org/10.1016/j.neuron.2022.10.006

Keywords: COVID-19; long COVID; cognitive impairment; microglia; myelin; astrocytes; hippocampal neurogenesis; post-acute infection syndromes; PAISs; SARS-CoV-2; EBV; HSV; autoimmunity; microvascular disease; blood-brain-barrier

Angeli F, Reboldi G, Trapasso M, Zappa M, Spanevello A, Verdecchia P.

COVID-19, vaccines and deficiency of ACE2 and other angiotensinases. Closing the loop on the „Spike effect“

Eur J Intern Med. 2022 Sep;103:23-28
> https://www.ejinme.com/article/S0953-6205(22)00234-5/fulltext

Keywords: SARS-CoV-2; COVID-19; ACE2; Vaccines; Renin-angiotensin-aldosterone system; Therapy; Olygopeptodases; POP; PRCP

Van Oosterwijck J, Marusic U, De Wandele I, et al.

Reduced Parasympathetic Reactivation during Recovery from Exercise in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

J Clin Med. 2021 Sep 30;10(19):4527
> https://doi.org/10.3390/jcm10194527